Does large airway intervention for patients with malignant disease result in early clinical benefit?

M. Wilde, A. Sheth, B. Madden (London, United Kingdom)

Source: Annual Congress 2008 - Hot and cold techniques
Session: Hot and cold techniques
Session type: Thematic Poster Session
Number: 3423
Disease area: Thoracic oncology

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
M. Wilde, A. Sheth, B. Madden (London, United Kingdom). Does large airway intervention for patients with malignant disease result in early clinical benefit?. Eur Respir J 2008; 32: Suppl. 52, 3423

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Does large airway intervention for patients with malignant disease result in early clinical benefit
Source: Eur Respir J 2007; 30: Suppl. 51, 434s
Year: 2007

Why we should improve current practice of diagnosing and treating pulmonary large cell neuroendocrine carcinomas in patients with advanced disease
Source: Eur Respir J, 50 (4) 1701658; 10.1183/13993003.01658-2017
Year: 2017



Does the method of interventional bronchoscopy used influence the survival of patients with malignant stenosis of the large airways ?
Source: International Congress 2017 – Bronchoscopy: from stents to practical tips and tricks
Year: 2017

Is the S-ECP/Eo ratio of any benefit for diferential diagnosis of early childhood bronchial asthma?
Source: Eur Respir J 2004; 24: Suppl. 48, 612s
Year: 2004

Which severe COVID-19 patients may benefit the most from pulmonary rehabilitation?
Source: Virtual Congress 2021 – Respiratory function after COVID-19 and mechanical ventilation
Year: 2021



The comparison of sarcoidosis patients with benign and recurrent clinical course of the disease
Source: Eur Respir J 2005; 26: Suppl. 49, 331s
Year: 2005

Managing the initial treatment and multiple relapses in a small cell lung cancer patient with limited disease
Source: International Congress 2018 – CC3 Lung cancer: personalised treatment and palliative care
Year: 2018


Does a predominant clinical COPD phenotype predict different outcome responses to pulmonary rehabilitation?
Source: Annual Congress 2012 - The best posters in pulmonary rehabilitation and chronic care
Year: 2012


Adding an invasive procedure will not necessarily change treatment or outcome of NSCLC patients with preoperative clinical N1 disease
Source: Eur Respir J, 51 (4) 1800084; 10.1183/13993003.00084-2018
Year: 2018



Adding an invasive procedure will not necessarily change treatment or outcome of NSCLC patients with preoperative clinical N1 disease
Source: Eur Respir J, 51 (4) 1800410; 10.1183/13993003.00410-2018
Year: 2018



Evaluating the effects of pulmonary rehabilitation in patients with COPD in early and late disease stages.
Source: Annual Congress 2008 - Impact of rehabilitation programmes in COPD and non-COPD patients
Year: 2008

Small airways function: evaluation in a population of adult patients with severe asthma and potential use as a response biomarker for anti-IL5 therapy
Source: Virtual Congress 2020 – Monoclonal antibodies; randomised controlled trials and real-world studies in asthma
Year: 2020

Patients with persistent asthma may have poor disease control despite normal lung function: baseline data from a pan-European real-life study
Source: Annual Congress 2009 - Persistent asthma: still an uncontrolled disease requiring new treatments strategies in 2009
Year: 2009

Improvements in activation for self-management in patients with chronic airway disease via the COPDnet diagnostic trajectory in secondary care; a pilot study.
Source: International Congress 2018 – Integrated care and non-pharmacological management of COPD
Year: 2018


Does aging affect the outcome of comprehensive pulmonary rehabilitation in patients with COPD?
Source: Eur Respir J 2003; 22: Suppl. 45, 426s
Year: 2003

Are invasive physiological measures necessary for an optimal setting of pressure support in young patients with cystic fibrosis?
Source: Annual Congress 2003 - Physiology of NIV: understanding the effects and chosing the best settings
Year: 2003


The clinical impact of adherence to therapy in airways disease
Source: Breathe, 17 (2) 210039; 10.1183/20734735.0039-2021
Year: 2021



How to manage a patient with COPD - early identification and how to prevent progression
Source: ERS Satellites 2021
Year: 2021

Identifying patients with severe asthma that will be benefit from biological therapy
Source: Virtual Congress 2020 – Rethinking asthma
Year: 2020